TIDMIDP

RNS Number : 8839I

InnovaDerma PLC

16 December 2020

LEI: 213800WRAP6W8VDL6B38

InnovaDerma PLC

("InnovaDerma" or the "Group")

Results of the Annual and General Meetings and Directorate Change

InnovaDerma (LSE: IDP), a UK developer of beauty, personal care and life science products, is pleased to announce that at its Annual General Meeting ("AGM") and General Meeting ("GM") held earlier today, all resolutions, were duly passed.

AGM Resolutions

Resolutions 9 and 10 were proposed as special resolutions. All other resolutions were proposed as ordinary

resolutions.   The proxy voting results for each resolution are as follows: 
 
 RESOLUTIONS                 Votes For      %      Votes Against    %     Votes Cast   Vote withheld 
 1. To receive 
  and adopt the 
  annual accounts 
  for the year 
  ended 30 June 
  2020.                       3,992,377   100.00    0              0.00    3,992,377    0 
                            -----------  -------  --------------  -----  -----------  -------------- 
 2. To receive 
  and approve 
  the director's 
  remuneration 
  report for the 
  year ended 30 
  June 2020.                 3,961,740    99.76    9,674           0.24   3,971,414    20,963 
                            -----------  -------  --------------  -----  -----------  -------------- 
 3. To approve 
  the Directors' 
  Remuneration 
  Policy                     3,940,740    99.48    20,674          0.52   3,961,414    30,963 
                            -----------  -------  --------------  -----  -----------  -------------- 
 4. To reappoint 
  Elderton Audit 
  UK as auditors 
  of the company.             3,981,377   99.72     11,000         0.28   3,992,377     0 
                            -----------  -------  --------------  -----  -----------  -------------- 
 5. To authorise 
  the directors 
  to fix the remuneration 
  of the auditors.            3,971,564   100.00    0              0.00    3,971,564    20,813 
                            -----------  -------  --------------  -----  -----------  -------------- 
 6. To reappoint 
  Ross Andrews 
  as a director.             3,969,756    99.48    20,674          0.52   3,990,430    1,947 
                            -----------  -------  --------------  -----  -----------  -------------- 
 7. To reappoint 
  Mark Michael 
  Ward as a director.        3,928,433    98.45    61,977          1.55   3,990,430    1,947 
                            -----------  -------  --------------  -----  -----------  -------------- 
 8. To confer 
  on the Directors 
  authority to 
  allot securities 
  in accordance 
  with Section 
  551 of the Companies 
  Act 2006.                  3,959,943    99.76    9,674           0.24   3,969,617    22,760 
                            -----------  -------  --------------  -----  -----------  -------------- 
 9. To confer 
  on the Directors 
  power to allot 
  securities under 
  a disapplication 
  of Section 561 
  of the Companies 
  Act 2006.                  3,949,943    99.50    19,674          0.50   3,969,617    22,760 
                            -----------  -------  --------------  -----  -----------  -------------- 
 10. To authorise 
  the Company 
  to make market 
  purchases of 
  its own shares 
  for the purposes 
  of Sections 
  693 and 701 
  of the Companies 
  Act 2006.                  3,959,617    99.70    11,947          0.30   3,971,564    20,813 
                            -----------  -------  --------------  -----  -----------  -------------- 
 

GM resolutions

 
 RESOLUTIONS        Votes For     %     Votes Against    %     Vote Cast   Votes Withheld 
 1. To appoint 
  Simon Pyper 
  as a director.    3,889,595   94.78   214,097         5.22   4,103,692   10,900 
                   ----------  ------  --------------  -----  ----------  --------------- 
 2. To re-elect 
  Joseph Bayer 
  as a director.    3,984,199   96.83   130,393         3.17   4,114,592   0 
                   ----------  ------  --------------  -----  ----------  --------------- 
 

Directorate Change

As previously announced, Rodney Turner who has been a Non-executive Director of the Group since September 2014 has chosen not to stand for re-election and has stepped down from the Board from at the beginning of the General Meeting.

Following the passing of the resolution at the GM, the Group is pleased to announce the appointment of Simon Pyper a Non-Executive Director of the Group with immediate effect. Simon, will join the Nominations and Remuneration Committees and chair the Audit Committee thereby replacing Rodney's membership role in those committees. Simon was formerly the Chief Executive Officer and Chief Financial Officer of digital marketing group Be Heard Group plc. Simon was appointed Chief Financial Officer of Be Heard Group plc in May 2018 and undertook the role of CEO from September 2018. Prior to this, he was Chief Financial Officer of AIM listed GlobalData plc from 2007 to 2017. During his tenure, Simon oversaw its reverse takeover of TMN plc and admission to AIM and facilitated its acquisition led growth strategy. Simon is currently the Chief Financial Officer of Xenia Broking, one of the largest credit insurance brokers in the UK. He is a British citizen and resident of the UK.

The full text of all the resolutions can be found in the Notice of AGM and GM contained in the Group's Annual Report and Accounts which is available for viewing on the FCA's National Storage Mechanism at data.fca.org.uk/#/nsm/nationalstoragemechanism as well as from the Group's website at : https://www.innovaderma.com/company-publications

This announcement contains inside for the purposes of Article 7 of EU Regulation 596/2014.

Further enquiries

 
 InnovaDerma 
  Joe Bayer                           +61 417 870 743 
  Blake Hughes                        c/o TB Cardew 
 finnCap Ltd 
  Geoff Nash/Kate Bannatyne           +44 (0)207 220 0500 
  Alice Lane - Corporate Broking      www.finncap.com 
                                  ---------------------------- 
 TB Cardew 
  Shan Shan Willenbrock/              + 44 (0)7775 848537 
  Olivia Rosser                       + 44 (0)20 7930 0777 
                                      innovaDerma@tbcardew.com 
                                  ---------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGFFMFEMESSEFE

(END) Dow Jones Newswires

December 16, 2020 07:18 ET (12:18 GMT)

Innovaderma (LSE:IDP)
Gráfica de Acción Histórica
De Abr 2024 a May 2024 Haga Click aquí para más Gráficas Innovaderma.
Innovaderma (LSE:IDP)
Gráfica de Acción Histórica
De May 2023 a May 2024 Haga Click aquí para más Gráficas Innovaderma.